Microbiome Movement Oncology Response 2019 is a conference dedicated to harnessing and translating the microbiome to improve identification of patient responders.
Microbiome Movement Oncology Response 2019 covers topics such as:
- How –omics data are being integrating to inform cancer clinical decision making
- The mechanistic pathways underpinning the causality of the microbiome in cancer and consequential effects of cancer therapeutics on microbial dysbiosis
- The nutritional interventions for cancer treatment and prevention
- Translational applications of the microbiome in cancer 1) to improve clinical safety outcomes, 2) as a validated biomarker to predict patient response and 3) as an LBP monotherapy or adjuvant to enhance therapeutic efficacy (particularly in the context of immunotherapy)
- How to integrate the microbiome into existing oncology medical practice and drug development infrastructures
- Clinical experience to establish gold standards for cancer clinical trials incorporating the microbiome as a measurable endpoint
